Adaptation and validation of the Greek version of the Communication and Language Assessment questionnaire for persons with Multiple Sclerosis (CLAMS).

Communication Language Multiple sclerosis Patient reported outcome measure Validation

Journal

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
ISSN: 1873-5843
Titre abrégé: Arch Clin Neuropsychol
Pays: United States
ID NLM: 9004255

Informations de publication

Date de publication:
09 Mar 2024
Historique:
received: 23 10 2023
revised: 05 12 2023
accepted: 03 02 2024
medline: 11 3 2024
pubmed: 11 3 2024
entrez: 11 3 2024
Statut: aheadofprint

Résumé

The aim of the present study was to validate the Communication and Language Assessment questionnaire for persons with Multiple Sclerosis (CLAMS) into the Greek language. 106 Persons with Multiple Sclerosis (PwMS) and 51 healthy controls (HCs) participated in this study. We evaluated patients' cognitive abilities with the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). All PwMS completed the CLAMS and three additional questionnaires (Speech Pathology-Specific Questionnaire for persons with Multiple Sclerosis, SMS; Stroke and Aphasia Quality of Life Scale-39, SAQOL-39; the Beck Depression Inventory Fast Screen, BDI-FS), and all HCs filled in the CLAMS. The internal consistency of the CLAMS was excellent (a = 0.933) for the PwMS and a significant difference was found between PwMS and HCs for the total CLAMS score. Statistical analyses showed a significant positive correlation between the CLAMS and the other questionnaires (SMS, BDI, and SAQOL-39) and a statistically significant negative correlation between the CLAMS and the three subtests of the BICAMS (Symbol Digit Modalities Test, Greek Verbal Learning Test-II, and Brief Visuospatial Memory Test-Revised). There was no correlation between the CLAMS and participants' age, disease duration, and disease type. The Greek version of the CLAMS is a valid self-reported questionnaire for the evaluation of language and communication symptoms in PwMS.

Identifiants

pubmed: 38462980
pii: 7624807
doi: 10.1093/arclin/acae015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Nefeli Dimitriou (N)

Department of Speech and Language Therapy, University of Ioannina, Ioannina, Greece.

Grigorios Nasios (G)

Department of Speech and Language Therapy, University of Ioannina, Ioannina, Greece.

Anastasia Nousia (A)

Department of Speech and Language Therapy, University of Peloponnese, Kalamata 24100, Greece.

Emmanouil Anyfantis (E)

Department of Speech and Language Therapy, University of Ioannina, Ioannina, Greece.

Lambros Messinis (L)

Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Georgios Dimakopoulos (G)

BIOSTATS, Science and Technology Park of Epirus, Ioannina, Greece.

Sarah El-Wahsh (S)

Discipline of Speech Pathology, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.

Christos Bakirtzis (C)

B' Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Vasiliki Kostadima (V)

Department of Neurology, University of Ioannina Medical School, Ioannina, Greece.

Spiridon Konitsiotis (S)

Department of Neurology, University of Ioannina Medical School, Ioannina, Greece.

Classifications MeSH